Uniphyl and Basal cell carcinoma - a phase IV clinical study of FDA data

Summary:

Basal cell carcinoma is found among people who take Uniphyl, especially for people who are female, 60+ old.

The phase IV clinical study analyzes which people take Uniphyl and have Basal cell carcinoma. It is created by eHealthMe based on reports of 2,850 people who have side effects when taking Uniphyl from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 17, 2022

2,850 people reported to have side effects when taking Uniphyl.
Among them, 20 people (0.7%) have Basal cell carcinoma.


What is Uniphyl?

Uniphyl has active ingredients of theophylline. eHealthMe is studying from 2,688 Uniphyl users for its effectiveness, alternative drugs and more.

What is Basal cell carcinoma?

Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills) is found to be associated with 1,790 drugs and 1,116 conditions by eHealthMe.

Number of Uniphyl and Basal cell carcinoma reports submitted per year:

Could Uniphyl cause Basal cell carcinoma?

Gender of people who have Basal cell carcinoma when taking Uniphyl *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Basal cell carcinoma when taking Uniphyl *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Uniphyl *:

  1. Spiriva: 20 people, 100.00%
  2. Singulair: 20 people, 100.00%
  3. Lipitor: 20 people, 100.00%
  4. Fosamax: 20 people, 100.00%
  5. Ativan: 20 people, 100.00%
  6. Alvesco: 20 people, 100.00%
  7. Advair Hfa: 20 people, 100.00%
  8. Formoterol Fumarate: 16 people, 80.00%
  9. Serax: 14 people, 70.00%
  10. Norvasc: 6 people, 30.00%

Common side effects people have besides Basal cell carcinoma *:

  1. The Flu (the flu is caused by an influenza virus): 20 people, 100.00%
  2. High Blood Cholesterol: 20 people, 100.00%
  3. Asthma: 20 people, 100.00%
  4. Breast Neoplasm (non cancerous tumour of breast): 20 people, 100.00%
  5. Breath Sounds Abnormal: 20 people, 100.00%
  6. Breathing Difficulty: 20 people, 100.00%
  7. Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 20 people, 100.00%
  8. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 20 people, 100.00%
  9. Cushing's Syndrome (obesity, a rounded face, increased fat): 20 people, 100.00%
  10. Cushingoid (obesity and weakening of the muscles): 20 people, 100.00%

Common conditions people have *:

  1. Asthma: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Uniphyl and have Basal cell carcinoma?

Check whether Basal cell carcinoma is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

How severe was Basal cell carcinoma and when was it recovered:

Expand to all the drugs that have ingredients of theophylline:

Alternative drugs to, pros and cons of Uniphyl:

Common Uniphyl side effects:

Browse all side effects of Uniphyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Basal cell carcinoma treatments and more:

COVID vaccines that are related to Basal cell carcinoma:

Common drugs associated with Basal cell carcinoma:

All the drugs that are associated with Basal cell carcinoma:

Common conditions associated with Basal cell carcinoma:

All the conditions that are associated with Basal cell carcinoma:

How the study uses the data?

The study uses data from the FDA. It is based on theophylline (the active ingredients of Uniphyl) and Uniphyl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: